Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 19,635 | 0 | 12,475 | 3,847 | 1,573 |
| Gross Profit | 19,635 | N/A | 12,475 | 3,847 | 1,573 |
| Operating Expenses | 36,915 | 0 | 46,333 | 36,864 | 9,025 |
| Operating Income | -17,280 | N/A | -33,858 | -33,017 | -7,452 |
| Other Income | 647 | 0 | -140,584 | -124,298 | 3 |
| Pre-tax Income | -16,633 | 0 | -174,442 | -157,315 | -7,449 |
| Net Income Continuous | -16,633 | N/A | -174,442 | -157,315 | -7,449 |
| Net Income | $-16,633 | $N/A | $-174,442 | $-157,315 | $-7,449 |
| EPS Basic Total Ops | -0.97 | N/A | N/A | N/A | -0.44 |
| EPS Basic Continuous Ops | -0.97 | N/A | N/A | N/A | -0.44 |
| EPS Diluted Total Ops | -0.97 | N/A | N/A | N/A | -0.44 |
| EPS Diluted Continuous Ops | -0.97 | N/A | N/A | N/A | -0.44 |
| EBITDA(a) | $-17,129 | $N/A | $-33,858 | $-33,017 | $-7,399 |